Literature DB >> 33573711

Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013.

Ania Zylbersztejn1, Lucy Pembrey2, Harvey Goldstein1, Guy Berbers3, Rutger Schepp3, Fiona van der Klis3, Charles Sande4, Dan Mason5, John Wright5, Rosalind Smyth6, Pia Hardelid1.   

Abstract

BackgroundBronchiolitis caused by respiratory syncytial virus (RSV) is a major cause of mortality and morbidity in infants.AimTo describe RSV epidemiology in children in the community in a high-income setting.MethodsWe used stored blood samples from the United Kingdom Born in Bradford cohort study that had been collected at birth, age 1 and 2 years old, tested for IgG RSV postfusion F antibody and linked to questionnaires and primary and hospital care records. We used finite mixture models to classify children as RSV infected/not infected according to their antibody concentrations at age 1 and 2 years. We assessed risk factors for primary RSV infection at each age using Poisson regression models.ResultsThe study cohort included 700 children with cord blood samples; 490 had additional blood samples taken at both ages 1 and 2 years old. Of these 490 children, 258 (53%; 95% confidence interval (CI): 48-57%) were first infected with RSV at age 1, 99 of whom (38%; 95% CI: 33-43%) had been in contact with healthcare during peak RSV season (November-January). Having older siblings, birth in October-June and attending formal childcare were associated with risk of RSV infection in infancy. By age 2, a further 164 of 490 children (33%; 95% CI: 29-38%) had been infected.ConclusionOver half of children experienced RSV infection in infancy, a further one third had evidence of primary RSV infection by age 2, and one in seven remained seronegative by their second birthday. These findings will inform future analyses to assess the cost-effectiveness of RSV vaccination programmes in high-income settings.

Entities:  

Keywords:  RSV; child; infant; respiratory syncytial virus; respiratory viruses; serological survey

Mesh:

Year:  2021        PMID: 33573711      PMCID: PMC7879500          DOI: 10.2807/1560-7917.ES.2021.26.6.2000023

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  28 in total

1.  Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.

Authors:  A H Brandenburg; J Groen; H A van Steensel-Moll; E C Claas; P H Rothbarth; H J Neijens; A D Osterhaus
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  Cohort Profile: the Born in Bradford multi-ethnic family cohort study.

Authors:  John Wright; Neil Small; Pauline Raynor; Derek Tuffnell; Raj Bhopal; Noel Cameron; Lesley Fairley; Debbie A Lawlor; Roger Parslow; Emily S Petherick; Kate E Pickett; Dagmar Waiblinger; Jane West
Journal:  Int J Epidemiol       Date:  2012-10-12       Impact factor: 7.196

4.  Respiratory syncytial virus infections within families.

Authors:  C B Hall; J M Geiman; R Biggar; D I Kotok; P M Hogan; G R Douglas
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

Review 5.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; D James Nokes; Bradford D Gessner; Mukesh Dherani; Shabir A Madhi; Rosalyn J Singleton; Katherine L O'Brien; Anna Roca; Peter F Wright; Nigel Bruce; Aruna Chandran; Evropi Theodoratou; Agustinus Sutanto; Endang R Sedyaningsih; Mwanajuma Ngama; Patrick K Munywoki; Cissy Kartasasmita; Eric A F Simões; Igor Rudan; Martin W Weber; Harry Campbell
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

6.  Time series analysis of RSV and bronchiolitis seasonality in temperate and tropical Western Australia.

Authors:  Alexandra B Hogan; Robert S Anderssen; Stephanie Davis; Hannah C Moore; Faye J Lim; Parveen Fathima; Kathryn Glass
Journal:  Epidemics       Date:  2016-05-25       Impact factor: 4.396

7.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

8.  The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease.

Authors:  E O Ohuma; E A Okiro; R Ochola; C J Sande; P A Cane; G F Medley; C Bottomley; D J Nokes
Journal:  Am J Epidemiol       Date:  2012-10-11       Impact factor: 4.897

9.  Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.

Authors:  Timothy M Kinyanjui; Thomas A House; Moses C Kiti; Patricia A Cane; David J Nokes; Graham F Medley
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

10.  The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya.

Authors:  Patrick K Munywoki; Dorothy C Koech; Charles N Agoti; Clement Lewa; Patricia A Cane; Graham F Medley; D J Nokes
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

View more
  1 in total

1.  Upper respiratory tract bacterial-immune interactions during respiratory syncytial virus infection in infancy.

Authors:  Christian Rosas-Salazar; Zheng-Zheng Tang; Meghan H Shilts; Kedir N Turi; Qilin Hong; Derek A Wiggins; Christian E Lynch; Tebeb Gebretsadik; James D Chappell; R Stokes Peebles; Larry J Anderson; Suman R Das; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2021-09-14       Impact factor: 14.290

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.